See also this year's filing and all EDGAR filings for this company.
PDF Report 0001730430_2024_Kiniksa_Pharmaceuticals_International_plc.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.5145147264114242, 'aggregate_val': 264719000, 'exp_sum': 174788000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 129427000, 'ResearchAndDevelopmentExpense': 76097000, 'remainder_Expenses': -30736000}} |
Graph
Absolute values for 0001730430, Kiniksa Pharmaceuticals International plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 276,297,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,250,000 |
| 2 | PropertyPlantAndEquipmentNet | 734,000 |
| 3 | remainder_Assets | 232,041,000 |
| 4 | LiabilitiesCurrent | 63,666,000 |
| 5 | LiabilitiesNoncurrent | 23,817,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 185,287,283 |
| 9 | ResearchAndDevelopmentExpense | 80,527,729 |
| 10 | remainder_Expenses | -125,140,858 |
| 11 | remainder_Revenues | 334,818,023 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 34,711 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 526,322,000 |
| 1 | Liabilities | 87,483,000 |
| 2 | Expenses | 140,674,154 |
| 3 | Revenues | 334,818,023 |
| 4 | StockholdersEquity | 438,839,000 |
| 5 | NetIncome | 194,143,869 |
| 6 | ComprehensiveNetIncome | 194,161,224 |
| 7 | BaseVar | 544,665,944 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.75 |
| 9 | EconomicCapitalRatio | 4.21 |
Edgar->Model Mapping
Feature Distribution
Change over Time
